South Korean pharmaceutical giant Samsung Biologics is making a major acquisition in the D.C. suburbs to establish its first U.S. manufacturing facility. The company reached an agreement to acquire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback